Share / Export Citation / Email / Print / Text size:

Postępy Mikrobiologii - Advancements of Microbiology

Polish Society of Microbiologists

Subject: Microbiology


ISSN: 0079-4252
eISSN: 2545-3149





Volume / Issue / page

Related articles

VOLUME 56 , ISSUE 4 (April 2017) > List of articles


Karol Abramczyk * / Anna Gałązka

Keywords : Biological weapons, microorganisms, terrorism, threat

Citation Information : Postępy Mikrobiologii - Advancements of Microbiology. Volume 56, Issue 4, Pages 395-404, DOI:

License : (CC BY-NC-ND 4.0)

Published Online: 22-May-2019



Due to the development of civilization, people’s needs and expectations increase. The global development of civilization, the desire of some countries to expand their borders and achieve a higher political, social and military influence, cause insecurity among the people. Security is one of the main factors for the proper functioning of individuals and whole societies. Currently, a major threat to people is terrorism. Especially dangerous is the use of biological weapons for this purpose, which significantly interferes with a sense of security and restricts the freedom of human activities. Currently, biological terrorism is a global threat associated with the use of weapons for political or religious reasons. The threat from radical religious fundamentalists is particularly dangerous.
The most common biological threat agents are microorganisms causing zoonoses, i.e. diseases which can be transmitted from animals to humans. The most dangerous are Bacillus anthracis, Yersinia pestis and Francisella tularensis. They are characterized by high virulence, ease of spread and the possibility to obtain and use them at low cost.
The aim of this paper is to characterize, based on the available literature, the most dangerous microorganisms which pose a potential threat to humans as biological warfare. The article also provides basic information on the diagnosis and treatment of diseases caused by pathogens which can be used in a bioterrorist attack.

Content not available PDF Share



1. Arciuch H.: Stale aktualne zagrożenie wąglik. Przegl. Epid. 55, 169–179 (2001)

2. Bah E.I., Fowler R.A. i wsp.: Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. New Eng. J. Med. 372, 40–47 (2014)

3. Bartkowiak J.: Badania molekularne w rozpoznawaniu i różnicowaniu chorób zakaźnych. Przegl. Epid. 57, 381–389 (2003)

4. Bausch D.G., Towner J.S., Dowell S.F. i wsp.: Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J. Infect Dis. 196, 142–147 (2007)

5. Bente D., Gren J., Strong J.E., Feldmann H.: Disease modeling for Ebola and Marburg viruses. Dis. Models Mech. 2, 12–17 (2009)

6. Chantau S., Ratsifasoamanana L., Rosoamanana B., Rahalison L., Randrianbelosoa J., Roux J. i wsp.: Plague’a reemerging disease in Madagascar. Emerg. Infect. Dis. 4, 101–104 (1998)

7. Cherkasskiy B.L.: A national register of historic and contemporary anthrax foci. J. Appl. Microbiol. 87, 192–195 (1999)

8. Chomiczewski K.: Zagrożenie bioterroryzmem. Przegl. Epid. 57, 349–353 (2002)

9. Chomiczewski K.: Patogeny zwierzęce jako broń biologiczna. Przegl. Epid. 57, 355–361 (2003)

10. Cisak E., Chmielewska-Badora J., Zwoliński J., Dutkiewicz J.: Choroby przenoszone przez kleszcze. Med. Ogol. 14, 280–289 (2008)

11. Cowan C., Jones H.A., Kaya Y.H., Perry R.D., Straley S.C.: Invasion of epithelial cells by Yersinia pestis: evidence for a Y. pestis – specific invasin. Infect. Immun. 68, 4523–4530 (2000)

12. Daniszewski P.: Dżuma (Yersinia pestis) – jako broń biologiczna. Intern. Letter Soc. Human. Sciences, 9, 84–94 (2013)

13. Daniszewski P.: Wąglik (Bacillus anthracis) – jako broń biologiczna. Intern. Letter Soc. Human. Sciences, 9, 74–83 (2013)

14. Dennis D.T.: Tularemia as a biological weapon. JAMA, 285, 2763–2773 (2001)

15. Dennis D.T., Tonat K. i wsp.: Tularemia as a biological weapon – medical and public health management. JAMA, 285, 2763–2773 (2001)

16. Dowell S.F., Ksiazek T.G. i wsp.: Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémiesa Kikwit. J. Infect. Dis. 179, 87–91 (1999)

17. Erricsson M.: Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J. Infect. Dis. 170, 110–114 (1994)

18. Fasanella A., Galante D., Garofolo G., Jones M.H.: Anthrax undervalued zoonosis. Vet. Microbiol. 140, 318–331 (2010)

19. Feldmann H., Geisbert T.W.: Ebola hemorrhagic fever. Lancet, 377, 849–862 (2011)

20. Fields K.A., Nilles M.L., Cowan C., Straley S.C.: Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect. Immun. 67, 5395–5408 (1999)

21. Franz D.R., McClain D.J. i wsp.: Clinical recognition and management of patients exposed to biological warfare agents. Clin. Lab. Med. 21(3), 435–473 (2001)

22. Gage K.L., Reynolds P.J. i wsp.: Cases of cat-associated human plague in the Western US, 1977–1998. Clin. Infect. Dis. 30, 893–900 (2000)

23. Garofolo G., Ciammaruconi A., Fasanella A., Scasciamacchia S., Adone R., Pittiglio V., Lista F.: SNR analysis: molecular investigation of an anthrax epidemic. BMC Vet. Res. 28, 6–11 (2010)

24. Geyik M.F., Akalın H.: Dünyada Tularemi (w) Francisella tularensis ve Tularemi, red. Ş. Gürcan, Nobel Tıp Kitabevleri, İstanbul, 2009, s. 99–106

25. Giraldi G., Marsella L.T.: Ebola Virus Disease Outbreak: What’s going on. Ann Ig., 27, 82–86 (2015)

26. Grolla A., Lucht A., Dick D., Strong J.E., Feldmann H.: Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bulletin de la Société de Pathologie Exotique, 98, 205–209 (2005)

27. Grygorczuk S., Hermanowska-Szpakowicz T.: Pałeczka Yersinia pestis jako niebezpieczna broń biologiczna. Med. Pr. 53, 343–348 (2002)

28. Gürcan Ş.: Epidemiology of Tularemia. Balkan Med. J. 31, 3–10 (2014)

29. Haas C.N.: On the quarantine period of Ebola. PLoS Curr. Out. DOI:10.1371/currents.outbreaks.2ab4b76ba7263ff0f084766e43abbd89 (2014)

30. Hermanowska-Szpakowicz T., Pancewicz S.: Obecność przeciwciał przeciwko Francisella tularensis u osób zamieszkujących północnowschodnią Polskę. Przegl. Epid. 50, 55–59 (1996)

31. Himsworth C.G.: The danger of lime use in agricultural anthrax disinfection procedures: the potential role of calcium in the preservation of anthrax spores. Can. Vet. J. 49, 1208–1210 (2008)

32. Hutchinson K.L., Rollin P.E.: Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect. Dis., 196, 357–363 (2007)

33. Inglesby T.V., Eitzen E. i wsp.: Plague as a biological weapon. Medical and public health menagement. JAMA, 283, 2281–2290 (2000)

34. Inglesby T.V., Parker G. i wsp.: Anthrax as a biological weapon. Medical and public health management. JAMA, 281, 1735–1737 (1999)

35. Jernigan D.B., Raghunathan P.L. i wsp.: Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg. Infect. Dis. 8, 1019–1028 (2002)

36. Johansson A., Forman M., Sjostedt A.: The development of tools for diagnosis of tularemia and typing of Francisella tularensis. Apmis, 112, 898–907 (2004)

37. Johnson E., Jaax N., White J., Jahring P.: Lethal experimental infections of rhesus monkeys by aerosolised Ebola virus. Int. J. Exp. Pathol. 76, 227–236 (1995)

38. Kałużewski S.: Wąglik (w) Choroby zakaźne i pasożytnicze- epidemiologia i profilaktyka, red. Magdzik W., Naruszewicz-Lesiuk D., Zieliński A., Alfa-Medica Press, Bielsko-Biała, 2007, s. 317–322

39. Kałużewski S.: Zagrożenia związane z zakażeniem pałeczkami z rodzaju Yersinia. Ogólnopolska Konferencja Naukowo-Szkoleniowa pt. „Biologiczne zagrożenia bezpieczeństwa kraju – ryzyko zagrożenia szczególnie niebezpiecznymi patogenami” 15–16 marca 2001, Warszawa [materiały konferencyjne] (2001)

40. Karahocagil M.K., Akdeniz N., Akdeniz H., Calka O., Karsen H., Bilici A., Bilgili S.G., Evirgen O.: Cutaneous anthrax in Eastern Turkey: a review of 85 cases. Clin. Exp. Dermatol. 33, 406–411 (2008)

41. Kilic S., Wagner D.M i wsp.: Water as Source of Francisella tularensis Infection in Humans, Turkey. Emerg. Infect. Dis. 21, 2213–2216 (2015)

42. Kiszmal E., Van Damme-Ostapowicz K.: Czy wirus Ebola jest nowym zagrożeniem epidemiologicznym świata? Pol. Przegl. Nauk o Zdrowiu, 1, 88–91 (2016)

43. Kłapeć T., Cholewa A.: Tularemia – wciąż groźna zoonoza, Med. Ogólna i Nauki o Zdrowiu, 17, 155–160 (2011)

44. Knap J.: Tularemia (w) Choroby zakaźne i pasożytnicze – epidemiologia i profilaktyka, red. Magdzik W., Naruszewicz-Lesiuk D., Zieliński A., Alfa-Medica Press, Bielsko-Biała, 2004, s. 288–293

45. Knap J.: Tularemia. (w): Choroby zakaźne i pasożytnicze – epidemiologia i profilaktyka. red. Magdzik W., Naruszewicz-Lesiuk D., Zieliński A., Alfa-Medica Press, Bielsko-Biała, 2007, s. 312–317

46. Kumar S.: Bubonic plague in Surat? Lancet, 345, 663–738 (1995)

47. Lacy D.B., Collier R.J.: Structure and function of anthrax toxin (w) Anthrax red. T.M. Koehler, Springer-Verlag Berlin Heidelberg, New York, 2002, s. 61–85

48. Leroy E.M., Gonzalez J.P., Baize S.: Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin. Microbiol Infect. 17, 964–976 (2011)

49. Leroy E.M., Pourrut X., Kumulungui B., Pourrut X., Rouquet P., Hassanin A., Yaba P., Délicat A., Paweska J.T., Gonzalez J.P., Swanepoel R.: Fruit bats as reservoirs of Ebola virus. Nature, 438, 575–576 (2005)

50. Łapiński T.W., Mięgoć H., Prokopowicz D., Kowalczuk-Kot A.: Zagrożenia toxokarozą i tularemią pracowników Białowieskiego Parku Narodowego. Przegl. Epid. 54, 367–374 (2000)

51. Makino S.I., Uchida I., Terakado N., Sasakawa C., Yoshikawa M.: Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J. Bacteriol. 171, 722–730 (1989)

52. Mandell G.L., Bennett J.E., Dolin R.: Principles and Practice of Infectious Diseases. Church. Livingstone, 1, 1–41 (1995)

53. Mielczarek P., Bagłak M.: Jersinioza – rzadko rozpoznawana choroba układu pokarmowego. Gastroenterologia Polska, 11, 69–74 (2004)

54. Murray B.E., Duchin J.S., Neill M.A.: IDSA Ebola Summary – August Open Forum. Infect. Dis. 1 (2014)

55. Naruszewicz-Lesiuk D.: Wąglik (w) Choroby zakaźne w Polsce i ich zwalczanie w latach 1919–1962, red. Kostrzewski J., PZWL, Warszawa, 1964, s. 140–147

56. Osiak B., Bartoszcze M., Gaweł J.: Franciscella tularensis – cechy zarazka, patogeneza, diagnostyka. Przegl. Epid. 60, 601–608 (2006)

57. Pacewicz S., Zajkowska M., Świerzbińska R., Kondrusik M., Grygorczuk S.S., Hermanowska-Szpakowicz T.: Czy kleszcze są wektorami tularemii u mieszkańców Połnocno-Wschodniej Polski? Med. Pr. 55, 189–192 (2004)

58. Parkhill J., Barrell B.G.: Genome sequence of Yersinia pestis, the causative agent of plague. Nature, 413, 523–526 (2001)

59. Rastawicki W., Jagielski M.: Tularemia. Post. Mikrobiol. 44, 265–273 (2005)

60. Ray T.K., Hutin Y.J., Murhekar M.V.: Cutaneous anthrax, West Bengal, India, 2007. Emerg. Infect. Dis. 15, 497–499 (2009)

61. Rymer W, Wroczyńska A, Nahorski W.L.: Co powinniśmy wiedzieć o zakażeniu wirusem Ebola? Med. Praktyczna, 9, 92–107 (2014)

62. Sergueev K.V., Yunxiu He., Borschel R.H., Mikeljon P., Nikolich, A., Filippov A.: Rapid and Sensitive Detection of Yersinia pestis Using Amplification of Plague Diagnostic Bacteriophages Monitored by Real-Time PCR. PLoS One, 5, e11337 (2010)

63. Siedner M.J., Gostin L.O., Cranmer H.H., Kraemer J.D.: Strengthening the Detection of and Early Response to Public Health Emergencies: Lessons from the West African Ebola Epidemic. PLoS Med. 12, e1001804 (2015)

64. Simonson T.S., Okinaka R.T. i wsp.: Bacillus anthracis in China and its relationship to worldwide lineages. BMC Microbiol. 9, 1–11 (2009)

65. Steiner D.J., Furuya Y., Metzger D.W.: Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity, Infect. Drug Resist. 7, 239–251 (2014)

66. Titball R.W., Leary S.E.: Plague. Br. Med. Bull. 54, 625–633 (1998)

67. Tokarska-Rodak M.: Tularemia – infekcja wywoływana przez Francisella tularensis, Med. Ogólna i Nauki o Zdrowiu, 21 56–61 (2015)

68. Turnbull P.C.B.: Anthrax history, disease and ecology (w) Anthrax, red. T.M. Koehler, Springer-Verlag Berlin Heidelberg, New York, 2002, s. 1–19

69. Werner S.B., Weidmer C.E., Nelson B.C., Nygaard G.S., Goethals R.M., Poland J.D.: Primary plague pneumonia contracted from a domestic cat at South Lake Tahoe, California. JAMA, 251, 929–931 (1984)

70. West T.E., von Saint André-von Arnim A.: Clinical Presentation and Management of Severe Ebola Virus Disease. Ann. American Thoracic Soc. 11, 1341–1350 (2014)

71. World Health Organization (WHO): WHO risk assessment. Human infections with Zaire Ebolavirus in West Africa, 24 June 2014, (26.07.2017)

72. Wróblewska M., Pancer K.: Wirus Ebola – aktualne zagrożenia i perspektywy kontroli zakażeń. Post. Nauk Med. 28, 34–41 (2015)

73. Zajkowska J., Hermanowska-Szpakowicz T.: Wąglik jako broń biologiczna. Med. Pr. 53, 167–172 (2002)